<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367035">
  <stage>Registered</stage>
  <submitdate>2/09/2014</submitdate>
  <approvaldate>12/09/2014</approvaldate>
  <actrnumber>ACTRN12614000980639</actrnumber>
  <trial_identification>
    <studytitle>Intravenous midazolam-droperidol (combination), droperidol (only) or olanzapine (only) for the acutely agitated patient:
A multi-centre, randomised, double-blind, controlled, clinical trial
</studytitle>
    <scientifictitle>A randomised clinical trial to compare the efficacy of the intravenous midazolam-droperidol combination, droperidol only and olanzepine only for sedation of the severely agitated patient </scientifictitle>
    <utrn />
    <trialacronym>SOOTHE Trial</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>severe agitation</healthcondition>
    <healthcondition>aggression</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Other mental health disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm 1: Single intravenous bolus of midazolam (5mg) plus droperidol (5mg). Arm 2: Single intravenous bolus of dropridol (10mg) Arm 3: Single intravenous bolus of olanzapine (10mg)</interventions>
    <comparator>The control treatment will be the midazolam-droperidol arm </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Time to sedation as defined by a sedation score of less than or equal to 2 on a 6 point scale (6=highly agitated &amp; violent, 0=asleep)   </outcome>
      <timepoint>Time to adequate sedation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Need for re-sedation &lt;60 minutes after achieving sedation (rescue drug requirement). Resedation will be required if the patient again becomse acutely agitated and is a danger to themsleves of others. </outcome>
      <timepoint>within 60 minutes of achieving adequate sedation initially   </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Adverse events including airway obstruction, hypoventilation, oxygen desaturation (&lt;90%), hypotension (&lt;90mmHg), movement disorders (eg. dystonic reactions, twitching), seizures, vomiting or aspiration. All events are assessed clinically (observation) or with stadard equipment (sphygmomanometer, saturation probe)</outcome>
      <timepoint>within 60 minutes of achieving adequate sedation initially   </timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Emergency Department patients aged 18-65 years who require IV drug sedation for acute agitation
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. known hypersensitivity or contraindication to the study drugs
2. reversible aetiology for agitation (hypotension, hypoxia, hypoglycaemia)
3. known pregnancy
4. acute alcohol withdrawal (particularly amenable to benzodiazepines alone)
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients requiring sedation will be determined by Emergency Physicians or Registrars. The next sequential study pack will be assigned to the patient. The study pack will contain the drugs randomly assigned to the patient. All drugs will be blinded. </concealment>
    <sequence>computer generated random numbers </sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>28/10/2014</anticipatedstartdate>
    <actualstartdate>20/10/2014</actualstartdate>
    <anticipatedenddate>30/03/2016</anticipatedenddate>
    <actualenddate>29/08/2015</actualenddate>
    <samplesize>342</samplesize>
    <actualsamplesize>349</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Royal Melbourne Hospital - City campus - Parkville</hospital>
    <hospital>St Vincent's Hospital (Melbourne) Ltd - Fitzroy</hospital>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Austin Hospital</primarysponsorname>
    <primarysponsoraddress>Studley Rd, Heidelberg, Vic 3084 </primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Australasian College for Emergency Medicine Research Foundation   </fundingname>
      <fundingaddress>34 Jeffcott Street, West Melbourne, Victoria, 3003   </fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Austin Hospital Medical Research Foundation</fundingname>
      <fundingaddress>Office for Research
Austin Hospital
Studly Road
Heidelberg
Victoria 
3084</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Royal Melbourne Hospital</sponsorname>
      <sponsoraddress>Royal Parade, Parkville, Vic 3052</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>St Vincent's Hospital</sponsorname>
      <sponsoraddress>Victoria Parade, Fitzroy, Victoria 3065</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Pharmacy College, Monash University</sponsorname>
      <sponsoraddress>Royal Parade, Parkville, Victoria 3052</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We believe that the combination of midazolam and droperidol will be superior in efficacy and safety to droperidol alone or olanzapine alone for patients with acute agitation</summary>
    <trialwebsite />
    <publication>none as yet</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Melbourne Health</ethicname>
      <ethicaddress>Royal Melbourne Hospital
Royal Parade
Parkville
Vic
3052</ethicaddress>
      <ethicapprovaldate>14/03/2014</ethicapprovaldate>
      <hrec>HREC/13/MH/363</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>David Taylor</name>
      <address>Emergency Department Austin Hospital Studley Road Heidelberg, Vic 3084 </address>
      <phone>+61 3 9496 4711</phone>
      <fax />
      <email>David.Taylor@austin.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>David Taylor</name>
      <address>Emergency Department Austin Hospital Studley Road Heidelberg, Vic 3084 </address>
      <phone>+61 3 9496 4711</phone>
      <fax />
      <email>David.Taylor@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>David Taylor</name>
      <address>Emergency Department Austin Hospital Studley Road Heidelberg, Vic 3084 </address>
      <phone>+61 3 9496 4711</phone>
      <fax />
      <email>David.Taylor@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>David Taylor</name>
      <address>Emergency Department Austin Hospital Studley Road Heidelberg, Vic 3084 </address>
      <phone>+61 3 9496 4711</phone>
      <fax />
      <email>David.Taylor@austin.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>